AKT1 and neoplasm: This tumor stage-dependent effect of AKT1 in breast cancer was first reported by Hutchinson et al. in 2004 by observing a decrease in tumor growth by suppressing AKT1 in a breast cancer mouse model, whereas the metastasis is increased [125].